TScan Therapeutics, Inc. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   ALLOHA-2 · T-Cell Receptor Engineered Donor T Cells in Subjects…ALLOHA-2 · T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

   Enrollment closed, study ongoing

   TScan Therapeutics, Inc.·Phase 3· NCT07702578· Registry history of NCT07702578 on ClinicalTrials.gov (opens the registry)

   Oct 5, 2026

2. Minor

   T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing…T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA)

   Enrollment closed, study ongoing

   TScan Therapeutics, Inc.·Phase 1· NCT05473910· Registry history of NCT05473910 on ClinicalTrials.gov (opens the registry)

   Oct 5, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.